LocationLocation:
Sutton
PositionPosition:
Cancer Therapeutics
Contract:Contract:
Permanent
External Advertising End DateAdvertising End Date:
16 Mar 2026

Key Information

Salary: £39,805 - £41,900 per annum. Commencement on the salary range is subject to comparable skills and experience. 
Reporting to: Alexis De Haven Brandon
Duration of Contract:
Hours per week: 35 hours per week (Full Time) 
Location: Sutton 
Closing Date: 16th March 2026

Job Details

Under the guidance of Alexis De Haven Brandon, we are seeking to recruit a Higher Scientific Officer.

We seek an experienced and dedicated in vivo scientist. The central aim of this position is to undertake in vivo technical work, playing a key role in supporting a variety of in vivo experiments and laboratory approaches. You will be a highly skilled in vivo scientist with sound knowledge and experience in in vivo approaches in a research setting. You will possess a Home Office Personal Licence.

 Your responsibilities will include planning and performing animal procedures, maintaining detailed records, and performing some routine laboratory tasks. This position offers an excellent opportunity for a highly skilled in vivo scientist with a passion for in vivo science, and animal welfare. There will occasionally be the need for out of hours work to ensure Home Office compliance, and the needs of the projects are met.

 The successful candidate will be a motivated individual with a strong background in in vivo techniques.

 We highly value diversity and encourage candidates from all backgrounds to apply.

About you

The successful candidate must have:

  • Personal Home Office Licence PIL A,B,C
  • BSc in life sciences or equivalent
  • Proven experience in a technical in vivo research setting - to include techniques such as dosing, surgical and sampling
  • Ability to plan and execute complex in vivo studies, to the highest ethical standards
  • Ability to work independently and collaboratively

Department/Directorate Information

The In Vivo Pharmacology team (IVP) provides in vivo support for all projects within the Centre for Cancer Drug Discovery (CCDD). The team carries out critical proof-of principle intervention studies and provides the essential pharmacological assays required to guide target validation in addition to the optimisation and selection of new drug candidates. Importantly, these experiments include the demonstration of drug effects in vivo, biomarker discovery and therapy studies, all of which underpin the drug discovery programs across the portfolio. The IVP works across a wide range of tumour models, including human tumour xenografts models (both cell line- and patient-derived xenografts), genetically engineered mouse models, organoid-based models and preclinical metastatic models. The team has specialised skills to develop and implement novel models, and supporting the design and implementation of studies, whilst complying with increasingly complex Home Office regulations.

What we offer

  • A dynamic and supportive research environment
  • Access to state-of-the-art facilities and professional development opportunities
  • Collaboration with leading researchers in the field
  • Competitive salary and pension

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Alexis De Haven Brandon: [email protected].

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

Other jobs like this

Location
Sutton
Position
Cancer Therapeutics
Contract:
Permanent
External Advertising End Date
16 Mar 2026
Location
Sutton
Position
Cancer Therapeutics
Contract:
Permanent
External Advertising End Date
12 Apr 2026
Location
Sutton
Position
Clinical Trials and Statistics Unit
Contract:
Fixed term
External Advertising End Date
08 Mar 2026